AI-generated summary
The authors studied 80 patients with chemotherapy-induced oral mucositis who received gallium-arsenide low-level laser therapy six days a week. They report that mucositis grade fell significantly after treatment and that the therapy was well tolerated. Changes in TNF-alpha and IL-6 varied by cancer type, and the authors conclude the mechanism does not seem fully linked to these cytokine changes.
- Participants
- 80
- Who or what was studied
- Patients with chemotherapy-induced oral mucositis across various malignancies, including breast cancer, head and neck cancer and lymphoma
- Limits stated in the abstract
- The abstract does not report a control group, and the cytokine findings were not consistent across cancer types.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sbmu.ac.ir.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Oral mucositis, Laser, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.